Anywhere in The TriangleClear the filters
Medical research stories in The Triangle
Newest first.
Arrow keys move through them
medical researchDr. Aden Mendoza Receives 2026 Neil Peart Neurosurgery Research Award - Glioblastoma Treatment & Research
Glioblastoma Foundation
Sep 30 · Durham
medical researchAlonzo Mourning Announced as Stuart Scott IMPACT Honoree at 6th Annual V Foundation for Cancer Research Boo-Yah
V Foundation
Sep 25 · Cary
medical researchThe 3rd Annual V Foundation for Cancer Research Chicago Epicurean Raises $1 Million
V Foundation
Sep 22 · Cary
The V Foundation for Cancer Research Announces 2026 Dick Vitale Pediatric Cancer Research Fund Grantees
V Foundation
Sep 8 · Cary
medical researchNew Clues on Why TIL Immunotherapy Works for Some Melanoma Patients — But Not All
A Cure In Sight
Aug 20 · Raleigh
The V Foundation for Cancer Research Eclipses the $500 Million Milestone in Grant Award Funding
V Foundation
Aug 18 · Cary
medical researchAdvances in Ocular Oncology Offer New Hope for Patients and Families
A Cure In Sight
Aug 16 · Raleigh
medical researchNew Targeted Therapy Shows Early Promise for Metastatic Uveal Melanoma
A Cure In Sight
Aug 12 · Raleigh
medical researchNew Immunotherapy Research May Help Strengthen Future Cancer Treatments
A Cure In Sight
Aug 8 · Raleigh
medical research28th Annual V Foundation for Cancer Research Wine Celebration Raises Nearly $7 Million to Accelerate Breakthrough Cancer Research
V Foundation
Aug 3 · Cary
medical researchNew Research May Improve How Doctors Predict Metastasis Risk in Uveal Melanoma
A Cure In Sight
Aug 3 · Raleigh
A Cure In Sight Earns Charity Navigator’s 2026 Four-Star Rating
A Cure In Sight
Jul 28 · Raleigh
medical researchHope Beyond a Rare Diagnosis: One Father’s Uveal Melanoma Journey Shows the Power of Clinical Trials
A Cure In Sight
Jul 22 · Raleigh
The V Foundation for Cancer Research Announces Recipients for the 2026 Breaking Barriers in Cancer Research Grant Award
V Foundation
Jul 20 · Cary
medical researchNew Blood Test Monitoring Tool Offers Additional Insight for Uveal Melanoma Care
A Cure In Sight
Jul 18 · Raleigh
medical researchGlioblastoma Foundation Marks 10 Years with New Push to Accelerate Personalized Treatment - Glioblastoma Treatment & Research
Glioblastoma Foundation
Jul 14 · Durham
medical researchThe V Foundation for Cancer Research and ESPN Announce Return of Annual ESPYS Week Charity Radio Auction
V Foundation
Jul 7 · Cary
medical researchWNBA Legends Unite Sports, Culture and Community in Support of the V Foundation for Cancer Research
V Foundation
Jun 23 · Cary
medical researchWhy Glioblastoma Treatment is Becoming More Personalized - Glioblastoma Treatment & Research
Glioblastoma Foundation
Apr 8 · Durham
medical researchPhase 1/2a study on Lisavanbulin Published in Journal Cell Reports Medicine - Glioblastoma Treatment & Research
Glioblastoma Foundation
Aug 14 · Durham
medical researchGenomic Testing: Transforming Glioblastoma Therapy - Glioblastoma Treatment & Research
Glioblastoma Foundation
Apr 11 · Durham
medical researchGenomic Testing and 2021 World Health Organization Glioblastoma Classification - Glioblastoma Treatment & Research
Glioblastoma Foundation
Jan 14 · Durham
medical researchGlioblastoma Foundation® Acquires Drug Lisavanbulin - Glioblastoma Treatment & Research
Glioblastoma Foundation
Oct 24 · Durham
Dr. Aden Mendoza Receives 2026 Neil Peart Neurosurgery Research Award - Glioblastoma Treatment & Research
Glioblastoma Foundation Names Dr. Aden Mendoza a 2026 Neil Peart Research Award Recipient
The Glioblastoma Foundation is pleased to announce that Dr. Aden Mendoza, MD, a neurosurgery resident at Duke University Medical Center, has been selected as a 2026 Neil Peart Neurosurgery Research Award recipient. The fellowship was established in memory of Neil Peart (1952–2020), the legendary drummer and lyricist of the Canadian rock band Rush, who passed away from glioblastoma in January 2020. The program supports promising neurosurgery residents who are committed to advancing research on this disease and improving the lives of the patients it affects.
Dr. Mendoza has shown a strong commitment to glioblastoma research throughout his scientific and medical training. His research focuses on the molecular basis of glioblastoma. Molecular and genomic markers can be used to not only diagnose glioblastoma, but also to measure response to treatment, among other things. As a Neil Peart Fellow, Dr. Mendoza will receive support from the Foundation to continue this work during his neurosurgical residency.
“We are delighted to welcome Dr. Mendoza as a 2026 Neil Peart Fellow,” said Gita Kwatra, PharmD, MBA, CEO of the Glioblastoma Foundation. “We established this fellowship to encourage young neurosurgeons to pursue glioblastoma research throughout their training and, ideally, their careers. By supporting the next generation of neurosurgeon-scientists, we aim to advance research that leads to better treatments for patients with glioblastoma.”
4 of 9 paragraphs
Glioblastoma Foundation&mission is to transform glioblastoma treatment & research. Learn how you can help us change this disease from being terminal to treatable.
Glioblastoma Foundation published this.
Open the story